SEC Comment Letter 0000000000-26-001947 to PULSE BIOSCIENCES, INC. (PLSE)
PULSE BIOSCIENCES, INC.
Date: Feb. 25, 2026 · CIK: 0001625101 · Accession: 0000000000-26-001947
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293596
Letter
Re: Pulse Biosciences, Inc. Registration Statement on Form S-3 Filed February 19, 2026 File No. 333-293596 Dear Paul LaViolette:
February 25, 2026
Paul LaViolette Chief Executive Officer Pulse Biosciences, Inc. 601 Brickell Key Drive, Suite 1080 Miami, FL 33131
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and Services
cc: Adam Finerman, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> February 25, 2026 Paul LaViolette Chief Executive Officer Pulse Biosciences, Inc. 601 Brickell Key Drive, Suite 1080 Miami, FL 33131 Re: Pulse Biosciences, Inc. Registration Statement on Form S-3 Filed February 19, 2026 File No. 333-293596 Dear Paul LaViolette: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Adam Finerman, Esq. </TEXT> </DOCUMENT>